Clinical impairment of benzodiazepines - Relation between benzodiazepine concentrations and impairment in apprehended drivers

Drug and Alcohol Dependence

Volumn 68, Issue 2, 2002, Pages 131-141

  Bramness, Jørgen G ^a   Skurtveit, Svetlana ^b   Mørland, Jørg ^a  

^a Natl Inst of Forensic Toxicology   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Benzodiazepines; Concentration effect relationship; Drugged driving; Legal limits for benzodiazepines and driving; Psychomotor impairment

Indexed keywords

ALCOHOL; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; FLUNITRAZEPAM; NITRAZEPAM; OXAZEPAM; TRIAZOLAM;

ADULT; AGE; ALCOHOL BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRIVING ABILITY; DRUG BLOOD LEVEL; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; RISK; SAMPLING; TIME;

ADULT; ALCOHOL DRINKING; AUTOMOBILE DRIVING; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; HUMANS; MALE; NORWAY; PSYCHOMOTOR PERFORMANCE;

EID: 0036773716     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(02)00188-6     Document Type: Article

References (44)

1. Alha A.R. Blood alcohol and clinical inebriation in Finnish men. A medico-legal study. Ann. Acad. Sci. Fenn. (A26):1951;1.
2. Anderson E.W., Burns M. Standardized field sobriety test: a field study. Mercier-Guyon C., 14th International Conference on Alcohol, Drugs and Traffic Safety. 2:1997;635 The International Council on Alcohol, Drugs and Traffic Safety, Annecy, France.
3. Ashton H., Golding J.F. Tranquillisers: prevalence, predictors and possible consequences. Data from a large United Kingdom survey. Br. J. Addict. 84:(5):1989;541.
4. Ballenger J.C. Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. J. Clin. Psychiatry. 62:(19):2001;11.
5. Berghaus G., Friedel B. Aspects of time for the assessment of driver fitness under therapy with benzodiazepines. Mercier-Guyon C., Alcohol, Drugs and Traffic Safety. 2:1997;711 The International Council on Alcohol, Drugs and Traffic Safety, Annecy, France.
6. Berghaus G., Grass H. Concentration-effect relationship with benzodiazepine therapy. Mercier-Guyon C., Alcohol, Drugs and Traffic Safety. 2:1997;705 The International Council on Alcohol, Drugs and Traffic Safety, Annecy, France.
7. Blin O., Jacquet A., Callamand S., Jouve E., Habib M., Gayraud D., Durand A., Bruguerolle B., Pisano P. Pharmacokinetic-pharmacodynamic analysis of amnesic effects of lorazepam in healthy volunteers. Br. J. Clin. Pharmacol. 48:(4):1999;510.
8. Bramness J.G., Skurtveit S., Mørland J. Detection of zopiclone in drivers. A sign of misuse and abuse. Tidsskr. Nor. Laegeforen. 119:(19):1999;2820.
9. Bramness J.G., Skurtveit S., Grung M., Mørland J. Centrally acting muscle relaxants: abuse potential and traffic hazards. Tidsskr. Nor. Laegeforen. 120:(17):2000;1966.
10. Campbell D.B. The use of kinetic-dynamic interactions in the evaluation of drugs. Psychopharmacology (Berl.). 100:(4):1990;433.
11. Christophersen A.S., Mørland J. Drugged driving, a review based on the experience in Norway. Drug Alcohol Depend. 47:1997;125.
12. Christophersen A.S., Skurtveit S., Grung M., Morland J. Rearrest rates among Norwegian drugged drivers compared with drunken drivers. Drug Alcohol Depend. 66:(1):2002;85.
13. Curran H.V. Benzodiazepines, memory and mood: a review. Psychopharmacology (Berl.). 105:(1):1991;1.
14. Ellinwood E.H. Jr., Linnoila M., Easler M.E., Molter D.W. Profile of acute tolerance to three sedative anxiolytics. Psychopharmacology (Berl.). 79:(2-3):1983;137.
15. Ellinwood E.H. Jr., Nikaido A.M., Heatherly D.G., Bjornsson T.D. Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms. Psychopharmacology (Berl.). 91:(2):1987;168.
16. File S.E. Tolerance to the behavioral actions of benzodiazepines. Neurosci. Biobehav. Rev. 9:(1):1985;113.
17. Gjerde H., Christophersen A.S., Skuterud B., Klemetsen K., Mørland J. Screening for drugs in forensic blood samples using EMIT urine assays. Forensic Sci. Int. 44:1990;179.
18. Gjerde H., Dahlin E., Christophersen A.S. Simultaneous determination of common benzodiazepines in blood using capillary gas chromatography. J. Pharm. Biomed. Anal. 10:(5):1992;317.
19. Goldberg L. Quantitative studies on alcohol tolerance in man. The influence of ethyl alcohol on sensory, motor and psychological functions referred to blood alcohol in normal and habituated individuals. Acta Physiol. Scand. 5:(Suppl. 16):1943.
20. Hobbs W., Rall T., Verdoorn T. Hypnotics and sedatives: ethanol. Hardman J., Limbird L., Goodman & Gilman's Pharmacological Basis of Therapeutics. 1995;361 McGraw-Hill, New York.
21. Ingum J., Bjorklund R., Bjørneboe A., Christophersen A.S., Dahlin E., Mørland J. Relationship between drug plasma concentrations and psychomotor performance after single doses of ethanol and benzodiazepines. Psychopharmacology (Berl.). 107:1992;11.
22. Ingum J., Beylich K.M., Mørland J. Amnesic effects and subjective ratings during repeated dosing of flunitrazepam to healthy volunteers. Eur. J. Clin. Pharmacol. 45:1993;235.
23. Ingum J., Bjørklund R., Volden R., Mørland J. Development of acute tolerance after oral doses of diazepam and flunitrazepam. Psychopharmacology. 113:1994;304.
24. Khanna J.M., Kalant H., Chau A., Shah G. Rapid tolerance and crosstolerance to motor impairment effects of benzodiazepines, barbiturates, and ethanol. Pharmacol. Biochem. Behav. 59:(2):1998;511.
25. Kuitunen T. Drug and ethanol effects on the clinical test for drunkenness: single doses of ethanol, hypnotic drugs and antidepressant drugs. Pharmacol. Toxicol. 75:(2):1994;91.
26. Kuitunen T., Mattila M.J., Seppala T. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol. Int. Clin. Psychopharmacol. 5:(Suppl. 2):1990;115.
27. Kuitunen T., Mattila M.J., Seppala T., Aranko K., Mattila M.E. Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests. Br. J. Clin. Pharmacol. 30:(3):1990;453.
28. Kuitunen T., Aranko K., Nuotto E., Lindbohm R., Mattila M.J., Korte T., Seppala T. The relationship between blood benzodiazepine concentrations and the clinical test for drunkenness in drivers suspected of driving under the influence of drugs. Alcohol Drugs Driving. 10:(2):1994;135.
29. Kuitunen T., Mererinne E., Seppala T. Correlation between blood diazepam concentrations and performance on clinical test for drunkenness in acute and chronic diazepam users. J. Traffic Med. 22:(3):1994;105.
30. Linnoila M., Erwin C.W., Brendle A., Simpson D. Psychomotor effects of diazepam in anxious patients and healthy volunteers. J. Clin. Psychopharmacol. 3:(2):1983;88.
31. McCall W.V. A psychiatric perspective on insomnia. J. Clin. Psychiatry. 62:(Suppl. 10):2001;27.
32. Mattila M.E., Kuitunen T., Veilahti J. Related coordinative, reactive and cognitive performances as impaired by drugs and alcohol: comparison with clinical test for driving fitness. J. Traffic Med. 21:(3):1993;101.
33. Mørland J. Driving under the influence of non-alcohol drugs. Forensic Sci. Rev. 12:2000;79.
34. Naja W.J., Pelissolo A., Haddad R.S., Baddoura R., Baddoura C. A general population survey on patterns of benzodiazepine use and dependence in Lebanon. Acta Psychiatr. Scand. 102:(6):2000;429.
35. O'Hanlon J.F., Vermeeren A., Uiterwijk M.M., van Veggel L.M., Swijgman H.F. Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies. Neuropsychobiology. 31:(2):1995;81.
36. Olfson M., Pincus H.A. Use of benzodiazepines in the community. Arch. Intern. Med. 154:(11):1994;1235.
37. Penttila, A., Tenhu, M., Kataja, M., 1974. Examination of Alcohol Intoxication in Cases of Suspected Drunken Drivers. II. A Mathematical Analysis of the Relationship between the Results of Clinical Testing and Blood Alcohol, Liikenneturva, Central Organization for Traffic Safety in Finland, Helsinki, p. 1.
38. Schulz R., Reimann I.W. Practice effect of volunteers in repeated psychometric testing. How to handle this intervening variable in clinical pharmacology studies? Methods Find. Exp. Clin. Pharmacol. 10:(10):1988;657.
39. Skurtveit S., Christophersen A.S., Mørland J. Female drivers suspected for drunken or drugged driving. Forensic Sci. Int. 75:1995;139.
40. Skurtveit S., Christophersen A.S., Mørland J. Kjøring under påvirkning av benzodiazepiner. Tidsskr. Nor. Laegeforen. 115:1995;200.
41. Skurtveit S., Abotnes B., Christophersen A.S. Drugged drivers in Norway with benzodiazepine detections. Forensic. Sci. Int. 125:(1):2002;75.
42. Taylor S., McCracken C.F., Wilson K.C., Copeland J.R. Extent and appropriateness of benzodiazepine use. Results from an elderly urban community. Br. J. Psychiatry. 173:1998;433.
43. Treiman D.M. GABAergic mechanisms in epilepsy. Epilepsia. 42:(Suppl. 3):2001;8.
44. van Laar M.W., Volkerts E.R., van Willigenburg A.P. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients. J. Clin. Psychopharmacol. 12:1992;86.